Video

Episode 5 - Setting the Tone: Current Therapeutic Goals

Appropriately managing the suite of cardiometabolic disorders has substantial clinical implications for cardiovascular health and prevention of cardiovascular disease (CVD). In the case of diabetes, dyslipidemias, and hypertension, achieving the goals of HbA1c <7%, LDL cholesterol <100 mg/dL, and blood pressure <140/90 sets the patient up with significant cardiovascular benefits, such as the prevention of downstream CVD, heart attack, heart failure, or stroke. Although there has always been a “disconnect” between what is known and what is actually done, on both clinician and patient levels, and at times, compromises have to be made to individualize treatments, there is still an awareness of the importance of managing the individual components of cardiometabolic disorders aggressively and effectively.


Related Videos
Matias Sanchez, MD
Screenshot of an interview with Nadine Barrett, PhD
dr carol regueiro
dr carol regueiro
Screenshot of Adam Colborn, JD during an interview
dr carol regueiro
Corey McEwen, PharmD, MS
dr linda bosserman
dr andrew leitner
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo